Profile
| Role | Director |
|---|---|
| Notability | 20/100 |
Board memberships
- Caris Life Sciences, Inc.
Updated Jul 16, 2026
HALBERT JON has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $990K.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-13 | CAI | Caris Life Sciences, Inc. | P — Open-market purchase | 68.0K | $14.56 | $990K |
| 2026-02-27 | CAI | Caris Life Sciences, Inc. | A — Grant or award | 2.5K | $20.06 | $50K |
| 2025-02-27 | CAI | Caris Life Sciences, Inc. | J — Other acquisition / disposition | 1.25M | $0.00 | |
| 2025-02-27 | CAI | Caris Life Sciences, Inc. | A — Grant or award | 16.1K | $0.00 |
HALBERT JON is a corporate insider — currently tracked as Director of Caris Life Sciences, Inc. (CAI). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 1 open-market purchases ($990K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live HALBERT JON profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.